IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis.
about
The role of the gut microbiota in the pathogenesis of antiphospholipid syndromeExamining the prevalence of non-criteria anti-phospholipid antibodies in patients with anti-phospholipid syndrome: a systematic reviewPathophysiology of the antiphospholipid syndromeAntiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via β2GPI and apoER2.Antiphospholipid antibodies: paradigm in transition.Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (II): thrombocytopenia and skin manifestations.Inhibition of nitric oxide and antiphospholipid antibody-mediated thrombosis.Plasma gelsolin facilitates interaction between β2 glycoprotein I and α5β1 integrinIgA anti-beta2-glycoprotein I autoantibodies are associated with an increased risk of thromboembolic events in patients with systemic lupus erythematosus.Chemical synthesis and characterization of wild-type and biotinylated N-terminal domain 1-64 of beta2-glycoprotein I.Annexin A5 anticoagulant activity in children with systemic lupus erythematosus and the association with antibodies to domain I of β2-glycoprotein I.New therapeutic targets for the antiphospholipid syndrome.Interpretation of laboratory data and need for reference laboratories.Autoantibodies directed against domain I of beta2-glycoprotein I.Variability in exposure of epitope G40-R43 of domain i in commercial anti-beta2-glycoprotein I IgG ELISAs.Treatment of the antiphospholipid syndrome.Resistance to annexin A5 anticoagulant activity in women with histories for obstetric antiphospholipid syndromePurified IgG from patients with obstetric but not IgG from non-obstetric antiphospholipid syndrome inhibit trophoblast invasion.Evaluating the conformation of recombinant domain I of β(2)-glycoprotein I and its interaction with human monoclonal antibodies.Antiphospholipid Syndrome during pregnancy: the state of the artMeasuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome.Binding of antiphospholipid antibodies to discontinuous epitopes on domain I of human beta(2)-glycoprotein I: mutation studies including residues R39 to R43Pathophysiological mechanisms in antiphospholipid syndromeEvaluation of the diagnostic potential of antibodies to beta2-glycoprotein 1 domain 1 in Chinese patients with antiphospholipid syndromeAntiphospholipid syndrome: laboratory testing and diagnostic strategies.The antiphospholipid syndrome: still an enigmaRecent advances in understanding antiphospholipid syndrome.Current management of antiphospholipid syndrome-related thrombosis.Revisiting the molecular mechanism of neurological manifestations in antiphospholipid syndrome: beyond vascular damage.The role of LRP8 (ApoER2') in the pathophysiology of the antiphospholipid syndrome.Domain I of beta2-glycoprotein I: its role as an epitope and the potential to be developed as a specific target for the treatment of the antiphospholipid syndrome.Antiphospholipid antibody profile: implications for the evaluation and management of patients.The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis.Antiphospholipid syndrome treatment beyond anticoagulation: are we there yet?β(2) -Glycoprotein I: evolution, structure and function.Guidelines on the investigation and management of antiphospholipid syndrome.Recent developments in our understanding of the antiphospholipid syndrome.Antibodies against domain I of β2-glycoprotein I: the one and only?Management of women with recurrent pregnancy losses and antiphospholipid antibody syndrome.Anti-β2-glycoprotein I antibodies.
P2860
Q26866133-DA57A363-F950-4710-A3B3-58A0609F3EF5Q28081765-B5242A48-7326-45AF-97A4-5CD0294CEC5DQ28267421-CB45731C-E1A0-42F9-8C6F-B7FC00502C94Q30497721-8E6FFA5D-C971-49B2-8AE3-B64C57619B6EQ33382848-C2B43B1D-E242-4FF4-9758-26C477B2B4ACQ33394044-067EE3BE-2408-4FFC-8C85-7A57C5F11E87Q33406588-7DBE26FE-F95D-484C-8B88-73C1536473BCQ33511345-BAD1F271-9535-43A3-8178-989FF52654B4Q33680556-FC856DEC-3EBC-4BB4-AC4A-8F15318CEE9BQ33844273-25396997-8EC1-4218-9894-B1A0CDBB42E5Q34069117-3FBAC730-EEF9-4D1A-B3FF-501C4CD1172CQ34140319-F7D7241E-8DAF-44D0-B276-2A6121A2E50AQ34283606-8FFA6CCA-A45D-4811-8A6B-3A848C8D65DAQ34467454-624EC041-D4AA-4DBC-90CD-C420824E6874Q34949493-B5CFF03D-08E1-4807-84D5-999D807E20CBQ35308972-02528A2F-DBC5-4BFB-9788-150C37A2C7D9Q35490209-2F5787DE-55A9-45E5-A26B-CF96B2854BEEQ35535795-9866647D-7265-450E-A2FF-A2BB0769E5FBQ35709692-2DC53539-C44F-4F69-8AFB-30C18BCF9D33Q35756040-6549E3E3-2D5B-4543-A83D-949D1DAA2686Q36037794-3EA78BEA-2C60-4733-8EFF-4185BC73349AQ36225236-45002A8C-4866-4F2A-940B-74ECE14F53BAQ36671159-54E5FCC7-FE7E-43B3-89FD-D959BFA96325Q36774243-33EFA0F7-D692-49C6-9639-A0559296E688Q36844544-83FD17A0-C3B7-40ED-9EC6-706AE6199738Q36928593-69FC053B-C1CB-4DFB-B38C-4A06FA9C1F4DQ37577693-2D31DE43-2BE5-4EF4-B254-777574852F50Q37642830-915A227F-9039-4F91-A214-F9F373263C4CQ37704593-EBE5708F-11E5-4B51-8181-ED954761F4BFQ37721602-37072E0A-FAD6-4934-B243-01A0082001FFQ37721607-850DF69F-5248-4570-8CA4-FB890716871CQ37721610-CB5E7A43-CE4F-4EAE-AFD7-82EC8FA6B9D0Q37721612-467F1F3B-1AC7-4FBF-84A5-DFD71B41111EQ37721617-C0B36C97-32F5-400A-93CC-309A0644C278Q37871051-79794883-7F69-43B2-8C3C-0D4E19F7A6E2Q37982121-E023C827-1810-4C87-A9FC-4A70736359FCQ37991066-506AB23F-C9B8-4E75-8621-4633D295A8A0Q38013590-62CD22A9-0DCF-4182-85FE-01F571045C9CQ38092150-F189F578-ACA1-4684-AE35-C7EA2AE61BB8Q38108396-1632F68D-30F9-4034-B320-B0220001A9DC
P2860
IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
IgG antibodies that recognize ...... ates strongly with thrombosis.
@en
IgG antibodies that recognize ...... ates strongly with thrombosis.
@nl
type
label
IgG antibodies that recognize ...... ates strongly with thrombosis.
@en
IgG antibodies that recognize ...... ates strongly with thrombosis.
@nl
prefLabel
IgG antibodies that recognize ...... ates strongly with thrombosis.
@en
IgG antibodies that recognize ...... ates strongly with thrombosis.
@nl
P2093
P1433
P1476
IgG antibodies that recognize ...... ates strongly with thrombosis.
@en
P2093
Bas de Laat
Philip G de Groot
Rolf T Urbanus
P304
P356
10.1182/BLOOD-2004-09-3387
P407
P577
2004-10-26T00:00:00Z